Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments

Viral Infections, Non-HIV

COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature

Crit Rev Oncol Hematol.

Di Lorenzo G, Di Trolio R, Kozlakidis Z, Busto G, Ingenito C, Buonerba L, Ferrara C, Libroia A, Ragone G, Ioio CD, Savastano B, Polverino M, De Falco F, Iaccarino S, Leo E

doi: 10.1016/j.critrevonc.2020.102991.

Viral Infections, Non-HIV

Trends in Prescribing of Antibiotics and Drugs Investigated for COVID-19 Treatment in U.S. Nursing Home Residents During the COVID-19 Pandemic

Clin Infect Dis

Gouin KA, Creasy S, Beckerson M, Wdowicki M, Hicks LA, Lind JN, Geller AI, Budnitz DS, Kabbani S

doi: 10.1093/cid/ciab225

Viral Infections, Non-HIV

Non-steroidal anti-inflammatory drugs in management of COVID-19; A systematic review on current evidence

Int J Clin Pract.

Yousefifard M, Zali A, Zarghi A, Madani Neishaboori A, Hosseini M, Safari S

doi: 10.1111/ijcp.13557.

Viral Infections, Non-HIV

Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19

Asia Pac J Ophthalmol (Phila).

Ruamviboonsuk P, Lai TYY, Chang A, Lai CC, Mieler WF, Lam DSC, for Asia-Pacific Vitreo-Retina Society.

doi: 10.1097/APO.0000000000000289.

Viral Infections, Non-HIV

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Trials.

Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Bond S, Hernan-Sancho E, Norton S, Cheriyan J, Cope A, Galloway J, Hall F, Jayne D, Wilkinson IB

doi: 10.1186/s13063-020-04535-4.

Viral Infections, Non-HIV

Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts

Ann Rheum Dis

Wong AY, MacKenna B, Morton CE, Schultze A, Walker AJ, Bhaskaran K, Brown JP, Rentsch CT, Williamson E, Drysdale H, Croker R, Bacon S, Hulme W, Bates C, Curtis HJ, Mehrkar A, Evans D, Inglesby P, Cockburn J, McDonald HI, Tomlinson L, Mathur R, Wing K, Forbes H, Eggo RM, Parry J, Hester F, Harper S, Evans SJ, Smeeth L, Douglas IJ, Goldacre B, OpenSAFELY Collaborative.

doi: 10.1136/annrheumdis-2020-219517

Viral Infections, Non-HIV

Patterns of drug, alcohol use and injection equipment sharing among people with recent injecting drug use or receiving opioid agonist treatment during and following hepatitis C virus treatment with direct-acting antiviral therapies: An international study

Clin Infect Dis.

Artenie AA, Cunningham EB, Dore GJ, Conway B, Dalgard O, Powis J, Bruggmann P, Hellard M, Cooper C, Read P, Feld JJ, Hajarizadeh B, Amin J, Lacombe K, Stedman C, Litwin AH, Marks P, Matthews GV, Quiene S, Erratt A, Bruneau J, Grebely J

doi: 10.1093/cid/ciz633.

Viral Infections, Non-HIV

Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study

Lancet Oncol.

Sud A, Torr B, Jones ME, Broggio J, Scott S, Loveday C, Garrett A, Gronthoud F, Nicol DL, Jhanji S, Boyce SA, Williams M, Riboli E, Muller DC, Kipps E, Larkin J, Navani N, Swanton C, Lyratzopoulos G, McFerran E, Lawler M, Houlston R, Turnbull C

doi: 10.1016/S1470-2045(20)30392-2.

Viral Infections, Non-HIV

Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China

Ann Oncol.

Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, Jia P, Guan HQ, Peng L, Chen Y, Peng P, Zhang P, Chu Q, Shen Q, Wang Y, Xu SY, Zhao JP, Zhou M

doi: 10.1016/j.annonc.2020.03.296.

Related content

COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature

Trends in Prescribing of Antibiotics and Drugs Investigated for COVID-19 Treatment in U.S. Nursing Home Residents During the COVID-19 Pandemic

Non-steroidal anti-inflammatory drugs in management of COVID-19; A systematic review on current evidence

Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts

Patterns of drug, alcohol use and injection equipment sharing among people with recent injecting drug use or receiving opioid agonist treatment during and following hepatitis C virus treatment with direct-acting antiviral therapies: An international study

Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study

Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China